4.5 Review

Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children

Journal

ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00277-023-05499-6

Keywords

Primary hemophagocytic lymphohistiocytosis; Isolated central nervous system HLH; Gene mutation; Prognosis; Immunological functional analysis

Categories

Ask authors/readers for more resources

This study analyzed the genetic variation and prognosis of primary hemophagocytic lymphohistiocytosis (pHLH) in children and the clinical features of isolated central nervous system HLH (CNS-HLH). The most common gene variants in pHLH patients were UNC13D, PRF1, and XIAP. CNS involvement was higher in pHLH patients compared to secondary HLH. Isolated CNS-HLH patients are often misdiagnosed, and hematopoietic stem cell transplantation (HSCT) may be beneficial for these patients. NK cell cytotoxicity and CD107a levels were not accurate in distinguishing pHLH from secondary HLH.
To analyze the genetic variation and prognosis of primary hemophagocytic lymphohistiocytosis (pHLH) in children and the clinical features of isolated central nervous system HLH (CNS-HLH). We retrospectively analyzed the clinical and genetic data of 480 HLH children admitted to our hospital from September 2017 to September 2022. There were 66 patients (13.75%) with pHLH, and the median age was 3.21 years (0.17-12.92 years). Variants in UNC13D (22/66, 33.33%), PRF1 (20/66, 30.30%) and XIAP (11/66, 16.67%) were the most common. More CNS involvement was observed in pHLH patients than in secondary hemophagocytic lymphohistiocytosis (sHLH) patients (50% vs. 25.3%, P = 0.001). Eight pHLH patients had isolated CNS-HLH at onset, which progressed to systemic HLH within 10-30 days to several years. Among them, five patients who underwent hematopoietic stem cell transplantation (HSCT) survived without CNS sequelae, and the three patients who did not undergo HSCT died of disease progression or recurrence. Determination of natural killer (NK) cell cytotoxicity and CD107a levels had low sensitivity and specificity in the diagnosis of pHLH, especially in patients with PRF1 and XIAP mutations. The 3-year overall survival (OS) was significantly lower in pHLH patients than in sHLH patients (74.5% +/- 14.7% vs. 89.2% +/- 3.53%, P = 0.021) and in patients with CNS involvement than in those without (53.8% +/- 26.07% vs. 94.4% +/- 10.58%, P = 0.012). There was a significant difference in OS among pHLH patients with different gene variants (P = 0.032); patients with PRF1 variants had poor 3-year OS, and patients with XIAP variants had good 3-year OS (50% +/- 28.22% and 100%, respectively). pHLH patients with distinct variants have different prognoses. Isolated CNS-HLH patients are easily misdiagnosed, and HSCT may be beneficial for these patients. Determination of NK cell cytotoxicity and CD107a levels cannot precisely distinguish pHLH from sHLH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available